Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04494347 · ClinicalTrials.gov registry record · NA

Watchman for Patients With Atrial Fibrillation Undergoing Transcatheter Mitral Valve Repair (WATCH-TMVR)

A NA study of Nonvalvular Atrial Fibrillation and Severe Degenerative Mitral Regurgitation, sponsored by Mayo Clinic.

Recruiting
Registry status
NA
Development phase
25
Enrollment target
2
Study locations

NCT04494347 is a NA study of Nonvalvular Atrial Fibrillation and Severe Degenerative Mitral Regurgitation that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 25 participants. The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04494347, a NA study of Nonvalvular Atrial Fibrillation and Severe Degenerative Mitral Regurgitation, is actively recruiting participants, sponsored by Mayo Clinic.

RECRUITING
Registry status
NA
Development phase
25 participants
Enrollment target
2
Study locations

Study Summary

WATCH-TMVR (Watchman for Patients with Atrial Fibrillation Undergoing Transcatheter Mitral Valve) Clinical Trial have the main objective to assess the feasibility of combining clinically indicated MitraClip TMVR and Watchman LAAO in one setting.Mayo Clinic will be the data coordinating center for this trial, which will include up to 3 sites.

Interventions

  • PROCEDURE MitraClip TMVR and Watchman LAAO

Study Locations (2)

Minnesota

  • Mayo Clinic - Rochester

Ontario

  • Ottawa Heart Institute - Ottawa

Trial Details

FieldValue
Enrollment Target 25 participants
Start Date 2020-11-01
Est. Completion 2026-01
Phase NA

Sponsor

Mayo Clinic

2,844 total trials

What the Registry Record Tells You About NCT04494347

The ClinicalTrials.gov registry entry for NCT04494347 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Nonvalvular Atrial Fibrillation appearing as the primary indexed condition, and to 1 intervention - of which MitraClip TMVR and Watchman LAAO is the first listed.

NCT04494347 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Minnesota, Ontario.

Frequently Asked Questions

What is clinical trial NCT04494347 about?

NCT04494347 is a clinical study titled "Watchman for Patients With Atrial Fibrillation Undergoing Transcatheter Mitral Valve Repair (WATCH-TMVR)". WATCH-TMVR (Watchman for Patients with Atrial Fibrillation Undergoing Transcatheter Mitral Valve) Clinical Trial have the main objective to assess the feasibility of combining clinically indicated MitraClip TMVR and Watchman LAAO in one setting.Mayo Clinic will be the data coordinating center for th...

What is the current status of trial NCT04494347?

This trial is currently recruiting. It is a NA study. The enrollment target is 25 participants. The study started on 2020-11-01. Estimated completion is 2026-01.

What conditions does trial NCT04494347 study?

This clinical trial studies the following conditions: Nonvalvular Atrial Fibrillation, Severe Degenerative Mitral Regurgitation.

What interventions are being tested in trial NCT04494347?

The interventions under investigation include: MitraClip TMVR and Watchman LAAO (PROCEDURE).

Who is sponsoring clinical trial NCT04494347?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04494347 being conducted?

This trial has 2 study locations across Minnesota, Ontario. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Nonvalvular Atrial Fibrillation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.